EUROFINS SCIENTIFIC (ERF.PA) Fundamental Analysis & Valuation
EPA:ERF • FR0014000MR3
Current stock price
68.84 EUR
-0.6 (-0.86%)
Last:
This ERF.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ERF.PA Profitability Analysis
1.1 Basic Checks
- In the past year ERF was profitable.
- ERF had a positive operating cash flow in the past year.
- In the past 5 years ERF has always been profitable.
- ERF had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 3.73%, ERF is in line with its industry, outperforming 50.00% of the companies in the same industry.
- ERF has a Return On Equity of 9.02%. This is in the better half of the industry: ERF outperforms 61.11% of its industry peers.
- With a decent Return On Invested Capital value of 6.74%, ERF is doing good in the industry, outperforming 66.67% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for ERF is below the industry average of 9.03%.
- The last Return On Invested Capital (6.74%) for ERF is above the 3 year average (6.44%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.73% | ||
| ROE | 9.02% | ||
| ROIC | 6.74% |
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
1.3 Margins
- ERF has a Profit Margin (5.62%) which is comparable to the rest of the industry.
- ERF's Profit Margin has declined in the last couple of years.
- ERF has a worse Operating Margin (10.87%) than 66.67% of its industry peers.
- In the last couple of years the Operating Margin of ERF has declined.
- The Gross Margin of ERF (21.39%) is worse than 77.78% of its industry peers.
- In the last couple of years the Gross Margin of ERF has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.87% | ||
| PM (TTM) | 5.62% | ||
| GM | 21.4% |
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
2. ERF.PA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ERF is destroying value.
- Compared to 1 year ago, ERF has less shares outstanding
- Compared to 5 years ago, ERF has less shares outstanding
- ERF has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.59 indicates that ERF is not a great score, but indicates only limited risk for bankruptcy at the moment.
- The Altman-Z score of ERF (2.59) is comparable to the rest of the industry.
- ERF has a debt to FCF ratio of 5.14. This is a neutral value as ERF would need 5.14 years to pay back of all of its debts.
- ERF's Debt to FCF ratio of 5.14 is fine compared to the rest of the industry. ERF outperforms 77.78% of its industry peers.
- ERF has a Debt/Equity ratio of 0.82. This is a neutral value indicating ERF is somewhat dependend on debt financing.
- ERF has a Debt to Equity ratio of 0.82. This is comparable to the rest of the industry: ERF outperforms 44.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 5.14 | ||
| Altman-Z | 2.59 |
ROIC/WACC0.89
WACC7.61%
2.3 Liquidity
- ERF has a Current Ratio of 1.09. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
- ERF has a Current ratio (1.09) which is in line with its industry peers.
- A Quick Ratio of 1.03 indicates that ERF should not have too much problems paying its short term obligations.
- ERF has a Quick ratio of 1.03. This is comparable to the rest of the industry: ERF outperforms 55.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.03 |
3. ERF.PA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 12.73% over the past year.
- Measured over the past years, ERF shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.09% on average per year.
- The Revenue has been growing slightly by 4.96% in the past year.
- The Revenue has been growing slightly by 6.05% on average over the past years.
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
3.2 Future
- The Earnings Per Share is expected to grow by 16.11% on average over the next years. This is quite good.
- The Revenue is expected to grow by 7.47% on average over the next years.
EPS Next Y6.38%
EPS Next 2Y11.18%
EPS Next 3Y13.59%
EPS Next 5Y16.11%
Revenue Next Year4.44%
Revenue Next 2Y5.49%
Revenue Next 3Y5.78%
Revenue Next 5Y7.47%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. ERF.PA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 18.51, which indicates a rather expensive current valuation of ERF.
- Compared to the rest of the industry, the Price/Earnings ratio of ERF indicates a somewhat cheap valuation: ERF is cheaper than 66.67% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.38, ERF is valued a bit cheaper.
- ERF is valuated rather expensively with a Price/Forward Earnings ratio of 17.97.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ERF indicates a somewhat cheap valuation: ERF is cheaper than 72.22% of the companies listed in the same industry.
- ERF's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.20.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.51 | ||
| Fwd PE | 17.97 |
4.2 Price Multiples
- 83.33% of the companies in the same industry are more expensive than ERF, based on the Enterprise Value to EBITDA ratio.
- ERF's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ERF is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.05 | ||
| EV/EBITDA | 10.46 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- A more expensive valuation may be justified as ERF's earnings are expected to grow with 13.59% in the coming years.
PEG (NY)2.9
PEG (5Y)N/A
EPS Next 2Y11.18%
EPS Next 3Y13.59%
5. ERF.PA Dividend Analysis
5.1 Amount
- ERF has a Yearly Dividend Yield of 1.13%. Purely for dividend investing, there may be better candidates out there.
- ERF's Dividend Yield is rather good when compared to the industry average which is at 0.52. ERF pays more dividend than 83.33% of the companies in the same industry.
- ERF's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.13% |
5.2 History
- The dividend of ERF is nicely growing with an annual growth rate of 16.09%!
Dividend Growth(5Y)16.09%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- ERF pays out 26.80% of its income as dividend. This is a sustainable payout ratio.
- The dividend of ERF is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP26.8%
EPS Next 2Y11.18%
EPS Next 3Y13.59%
ERF.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:ERF (4/16/2026, 10:18:02 AM)
68.84
-0.6 (-0.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29 2026-01-29/bmo
Earnings (Next)04-22 2026-04-22
Inst Owners35.09%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap12.12B
Revenue(TTM)7.30B
Net Income(TTM)409.70M
Analysts72
Price Target72.19 (4.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.13% |
Yearly Dividend0.6
Dividend Growth(5Y)16.09%
DP26.8%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.3%
PT rev (3m)9.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.79%
EPS NY rev (3m)-3.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-1.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.51 | ||
| Fwd PE | 17.97 | ||
| P/S | 1.66 | ||
| P/FCF | 14.05 | ||
| P/OCF | 8.66 | ||
| P/B | 2.67 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.46 |
EPS(TTM)3.72
EY5.4%
EPS(NY)3.83
Fwd EY5.57%
FCF(TTM)4.9
FCFY7.12%
OCF(TTM)7.95
OCFY11.55%
SpS41.46
BVpS25.81
TBVpS-4.57
PEG (NY)2.9
PEG (5Y)N/A
Graham Number46.4828 (-32.48%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.73% | ||
| ROE | 9.02% | ||
| ROCE | 9.27% | ||
| ROIC | 6.74% | ||
| ROICexc | 7.43% | ||
| ROICexgc | 23.86% | ||
| OM | 10.87% | ||
| PM (TTM) | 5.62% | ||
| GM | 21.4% | ||
| FCFM | 11.82% |
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
ROICexc(3y)7.17%
ROICexc(5y)9.25%
ROICexgc(3y)23.01%
ROICexgc(5y)30.49%
ROCE(3y)8.97%
ROCE(5y)11.81%
ROICexgc growth 3Y-10.94%
ROICexgc growth 5Y-13.82%
ROICexc growth 3Y-8.95%
ROICexc growth 5Y-10.36%
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
F-Score7
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 5.14 | ||
| Debt/EBITDA | 2.44 | ||
| Cap/Depr | 74.23% | ||
| Cap/Sales | 7.35% | ||
| Interest Coverage | 6.87 | ||
| Cash Conversion | 92.26% | ||
| Profit Quality | 210.5% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.59 |
F-Score7
WACC7.61%
ROIC/WACC0.89
Cap/Depr(3y)77.81%
Cap/Depr(5y)87.04%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.15%
Profit Quality(3y)205.64%
Profit Quality(5y)166.63%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
EPS Next Y6.38%
EPS Next 2Y11.18%
EPS Next 3Y13.59%
EPS Next 5Y16.11%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
Revenue Next Year4.44%
Revenue Next 2Y5.49%
Revenue Next 3Y5.78%
Revenue Next 5Y7.47%
EBIT growth 1Y-4.65%
EBIT growth 3Y-8.54%
EBIT growth 5Y-4.97%
EBIT Next Year81.58%
EBIT Next 3Y28.7%
EBIT Next 5Y24.78%
FCF growth 1Y9.1%
FCF growth 3Y21.91%
FCF growth 5Y-0.13%
OCF growth 1Y6.07%
OCF growth 3Y7.18%
OCF growth 5Y2.72%
EUROFINS SCIENTIFIC / ERF.PA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA.
What is the valuation status for ERF stock?
ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Fairly Valued.
What is the profitability of ERF stock?
EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for ERF stock?
The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ERF.PA) is 18.51 and the Price/Book (PB) ratio is 2.67.
What is the financial health of EUROFINS SCIENTIFIC (ERF.PA) stock?
The financial health rating of EUROFINS SCIENTIFIC (ERF.PA) is 4 / 10.